92 related articles for article (PubMed ID: 18383859)
1. Antiangiogenic properties of lupulone, a bitter acid of hop cones.
Siegel L; Miternique-Grosse A; Griffon C; Klein-Soyer C; Lobstein A; Raul F; Stephan D
Anticancer Res; 2008; 28(1A):289-94. PubMed ID: 18383859
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator.
Kaur G; Belotti D; Burger AM; Fisher-Nielson K; Borsotti P; Riccardi E; Thillainathan J; Hollingshead M; Sausville EA; Giavazzi R
Clin Cancer Res; 2004 Jul; 10(14):4813-21. PubMed ID: 15269157
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects.
Maffucci T; Piccolo E; Cumashi A; Iezzi M; Riley AM; Saiardi A; Godage HY; Rossi C; Broggini M; Iacobelli S; Potter BV; Innocenti P; Falasca M
Cancer Res; 2005 Sep; 65(18):8339-49. PubMed ID: 16166311
[TBL] [Abstract][Full Text] [Related]
4. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide.
Ferrari N; Pfeffer U; Dell'Eva R; Ambrosini C; Noonan DM; Albini A
Clin Cancer Res; 2005 Jun; 11(12):4610-9. PubMed ID: 15958647
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic activity of beta-eudesmol in vitro and in vivo.
Tsuneki H; Ma EL; Kobayashi S; Sekizaki N; Maekawa K; Sasaoka T; Wang MW; Kimura I
Eur J Pharmacol; 2005 Apr; 512(2-3):105-15. PubMed ID: 15840394
[TBL] [Abstract][Full Text] [Related]
6. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T
Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic activity of 11,11'-dideoxyverticillin, a natural product isolated from the fungus Shiraia bambusicola.
Chen Y; Zhang YX; Li MH; Zhao WM; Shi YH; Miao ZH; Zhang XW; Lin LP; Ding J
Biochem Biophys Res Commun; 2005 Apr; 329(4):1334-42. PubMed ID: 15766573
[TBL] [Abstract][Full Text] [Related]
8. Proapoptotic, antimigratory, antiproliferative, and antiangiogenic effects of commercial C-reactive protein on various human endothelial cell types in vitro: implications of contaminating presence of sodium azide in commercial preparation.
Liu C; Wang S; Deb A; Nath KA; Katusic ZS; McConnell JP; Caplice NM
Circ Res; 2005 Jul; 97(2):135-43. PubMed ID: 15976313
[TBL] [Abstract][Full Text] [Related]
9. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
[TBL] [Abstract][Full Text] [Related]
10. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.
Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; Béliveau R; Luis J
J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383
[TBL] [Abstract][Full Text] [Related]
11. Hypericin in the dark inhibits key steps of angiogenesis in vitro.
Martínez-Poveda B; Quesada AR; Medina MA
Eur J Pharmacol; 2005 Jun; 516(2):97-103. PubMed ID: 15921677
[TBL] [Abstract][Full Text] [Related]
12. [Study on antiangiogenesis effect of Vaccaria segetalis].
Feng L; Hua H; Qiu LY; Zhang LF; Jin J
Zhong Yao Cai; 2009 Aug; 32(8):1256-9. PubMed ID: 19960951
[TBL] [Abstract][Full Text] [Related]
13. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic concentrations of vinflunine increase the interphase microtubule dynamics and decrease the motility of endothelial cells.
Pourroy B; Honoré S; Pasquier E; Bourgarel-Rey V; Kruczynski A; Briand C; Braguer D
Cancer Res; 2006 Mar; 66(6):3256-63. PubMed ID: 16540678
[TBL] [Abstract][Full Text] [Related]
15. Matrigel cytometry: a novel method for quantifying angiogenesis in vivo.
Adini A; Fainaru O; Udagawa T; Connor KM; Folkman J; D'Amato RJ
J Immunol Methods; 2009 Mar; 342(1-2):78-81. PubMed ID: 19109967
[TBL] [Abstract][Full Text] [Related]
16. The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis.
Carmi Y; Voronov E; Dotan S; Lahat N; Rahat MA; Fogel M; Huszar M; White MR; Dinarello CA; Apte RN
J Immunol; 2009 Oct; 183(7):4705-14. PubMed ID: 19752225
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the antiangiogenic potential of AQ4N.
O'Rourke M; Ward C; Worthington J; McKenna J; Valentine A; Robson T; Hirst DG; McKeown SR
Clin Cancer Res; 2008 Mar; 14(5):1502-9. PubMed ID: 18316575
[TBL] [Abstract][Full Text] [Related]
18. Vascular-specific quantification in an in vivo Matrigel chamber angiogenesis assay.
Baker JH; Huxham LA; Kyle AH; Lam KK; Minchinton AI
Microvasc Res; 2006 Mar; 71(2):69-75. PubMed ID: 16545400
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic properties of viscum album extracts are associated with endothelial cytotoxicity.
Elluru SR; Duong Van Huyen JP; Delignat S; Prost F; Heudes D; Kazatchkine MD; Friboulet A; Kaveri SV
Anticancer Res; 2009 Aug; 29(8):2945-50. PubMed ID: 19661299
[TBL] [Abstract][Full Text] [Related]
20. Identification of HIV-1 Tat peptides for future therapeutic angiogenesis.
Ismail M; Henklein P; Huang X; Braumann C; Rückert RI; Dubiel W
Eur J Haematol; 2006 Aug; 77(2):157-65. PubMed ID: 16800839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
